WO2002026978A1 - Nouvelles proteines, genes codant ces proteines et leur procede d'utilisation - Google Patents

Nouvelles proteines, genes codant ces proteines et leur procede d'utilisation Download PDF

Info

Publication number
WO2002026978A1
WO2002026978A1 PCT/JP2001/008446 JP0108446W WO0226978A1 WO 2002026978 A1 WO2002026978 A1 WO 2002026978A1 JP 0108446 W JP0108446 W JP 0108446W WO 0226978 A1 WO0226978 A1 WO 0226978A1
Authority
WO
WIPO (PCT)
Prior art keywords
genes encoding
amino acid
acid sequence
seq
protein
Prior art date
Application number
PCT/JP2001/008446
Other languages
English (en)
French (fr)
Inventor
Shiken Sha
Hidehito Mukai
Yoshiko Aoki
Yoshisuke Nishi
Original Assignee
Japan Tobacco Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Tobacco Inc. filed Critical Japan Tobacco Inc.
Priority to AU2001292273A priority Critical patent/AU2001292273B2/en
Priority to AU9227301A priority patent/AU9227301A/xx
Priority to EP01972537A priority patent/EP1331268A4/en
Priority to US10/381,710 priority patent/US7303890B2/en
Priority to JP2002530741A priority patent/JPWO2002026978A1/ja
Priority to CA002423858A priority patent/CA2423858A1/en
Publication of WO2002026978A1 publication Critical patent/WO2002026978A1/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/243—Colony Stimulating Factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PCT/JP2001/008446 2000-09-27 2001-09-27 Nouvelles proteines, genes codant ces proteines et leur procede d'utilisation WO2002026978A1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
AU2001292273A AU2001292273B2 (en) 2000-09-27 2001-09-27 Novel proteins, genes encoding them and method of using the same
AU9227301A AU9227301A (en) 2000-09-27 2001-09-27 Novel proteins, genes encoding them and method of using the same
EP01972537A EP1331268A4 (en) 2000-09-27 2001-09-27 NOVEL PROTEINS, GENES ENCODING THESE PROTEINS AND THEIR USE
US10/381,710 US7303890B2 (en) 2000-09-27 2001-09-27 Proteins, genes encoding them and method of using the same
JP2002530741A JPWO2002026978A1 (ja) 2000-09-27 2001-09-27 新規タンパク質、それをコードする遺伝子、及びそれらの利用法
CA002423858A CA2423858A1 (en) 2000-09-27 2001-09-27 Novel proteins, genes encoding them and method of using the same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000-294191 2000-09-27
JP2000294191 2000-09-27

Publications (1)

Publication Number Publication Date
WO2002026978A1 true WO2002026978A1 (fr) 2002-04-04

Family

ID=18776843

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2001/008446 WO2002026978A1 (fr) 2000-09-27 2001-09-27 Nouvelles proteines, genes codant ces proteines et leur procede d'utilisation

Country Status (6)

Country Link
US (1) US7303890B2 (ja)
EP (1) EP1331268A4 (ja)
JP (1) JPWO2002026978A1 (ja)
AU (2) AU2001292273B2 (ja)
CA (1) CA2423858A1 (ja)
WO (1) WO2002026978A1 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180030415A (ko) * 2015-07-28 2018-03-22 포르슝스첸트룸 보르슈텔 라이브니츠 룽겐첸트룸 내독소의 측정을 위한 개선된 박테리아 내독소 시험

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0892050A2 (en) * 1997-07-08 1999-01-20 Smithkline Beecham Corporation Human HFIZG53
JPH11106400A (ja) * 1997-09-30 1999-04-20 Japan Tobacco Inc 顆粒球コロニー刺激因子誘導活性を有する抗体及びその医薬
WO2000060075A1 (fr) * 1999-04-01 2000-10-12 Japan Tobacco Inc. Nouvelles proteines, gene les codant et leur procede d'utilisation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1259618A2 (en) * 2000-03-01 2002-11-27 Incyte Genomics, Inc. Human enzyme molecules

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0892050A2 (en) * 1997-07-08 1999-01-20 Smithkline Beecham Corporation Human HFIZG53
JPH11106400A (ja) * 1997-09-30 1999-04-20 Japan Tobacco Inc 顆粒球コロニー刺激因子誘導活性を有する抗体及びその医薬
WO2000060075A1 (fr) * 1999-04-01 2000-10-12 Japan Tobacco Inc. Nouvelles proteines, gene les codant et leur procede d'utilisation

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
AOKI Y. ET AL.: "Selective stimulation of G-CSF gene expression in macrophages by a stimulatory monoclonal antibody as detected by a luciferase reporter gene assay", J. LEUKOC. BIOL., vol. 68, no. 5, November 2000 (2000-11-01), pages 757 - 764, XP002907462 *
See also references of EP1331268A4 *
YOSHISUKE NISHI ET AL.: "Kou-kinou koutai no kouritsuteki sentaku process no kaihatsu", BIO-TECHNOLOGY SYMPOSIUM YOKOUSHUU, vol. 15, 1997, pages 159 - 164, XP002907474 *
YOSHISUKE NISHI ET AL.: "Kou-kinou koutai no kouritsu-teki sentaku process no kaihatsu", BIO-TECHNOLOGY SYMPOSIUM YOKOUSHUU, vol. 16, 1998, pages 161 - 166, XP002907473 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180030415A (ko) * 2015-07-28 2018-03-22 포르슝스첸트룸 보르슈텔 라이브니츠 룽겐첸트룸 내독소의 측정을 위한 개선된 박테리아 내독소 시험
JP2018529978A (ja) * 2015-07-28 2018-10-11 フォルシュンクツェントラム ボルステル ライプニッツ ランゲンツェントラム エンドトキシンの測定のための、改良された細菌エンドトキシン試験
KR102630300B1 (ko) 2015-07-28 2024-01-26 에프. 호프만-라 로슈 아게 내독소의 측정을 위한 개선된 박테리아 내독소 시험

Also Published As

Publication number Publication date
JPWO2002026978A1 (ja) 2004-02-05
EP1331268A4 (en) 2005-01-19
US20040052789A1 (en) 2004-03-18
EP1331268A1 (en) 2003-07-30
AU9227301A (en) 2002-04-08
US7303890B2 (en) 2007-12-04
CA2423858A1 (en) 2003-03-26
AU2001292273B2 (en) 2007-11-15

Similar Documents

Publication Publication Date Title
MX348154B (es) Anticuerpos de enlace a il-1-beta y fragmentos de los mismos.
HK1071375A1 (en) Egviii endoglucanase and nucleic acids encoding the same egviii
WO2003020932A1 (fr) Nouvelles proteines de secretion et adn associe
WO2003052055A3 (en) Egvii endoglucanase and nucleic acids encoding the same
AU4981101A (en) Subtilisin variants
WO1998056927A3 (en) Nucleic acids encoding polypeptide having protease activity
WO2000075350A3 (en) Nucleic acid sequences encoding proteins involved in fatty acid beta-oxidation and methods of use
CA2269111A1 (en) Genes encoding plant transcription factors
CA2170515A1 (en) Nucleotide sequences for novel protein tyrosine phosphatases
WO2007029262A3 (en) Compositions and methods using same for the detection of viruses
WO2002008426A3 (en) Fh-binding protein of streptococcus pneumoniae
WO2007058267A8 (ja) 新規タンパク質及びそれをコードする遺伝子
WO2001098469A3 (en) Polypeptides having peroxidase activity and nucleic acids encoding same
EP1757687A4 (en) HLA BINDING PEPTIDE, PRE-STEP, DNA DOMAGING AND RECOMBINANT VECTOR
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor
WO2002026978A1 (fr) Nouvelles proteines, genes codant ces proteines et leur procede d'utilisation
WO2003022039A1 (fr) Procede permettant de conferer une resistance a un virus au moyen d'une proteine vegetale se liant a une proteine de transport de virus vegetal
AU782261C (en) Novel glycosyltransferase genes
GB2357507A (en) Peptide fragments of cholera toxin B or enterotoxin B as vaccine adjuvants
WO2002002771A3 (en) Human sparc-homologous (hsparc-h1) gene and methods and uses thereof
WO2003054158A3 (en) Rapidly maturing fluorescent proteins and methods for using the same
MXPA04000397A (es) Polipeptidos que tienen actividad catalitica de isomerasa de carotenoides, acidos nucleicos que los codifican y usos de los mismos.
EP0845536A3 (en) Protein having ethylenediamine-N,N'-disuccinic acid: ethylenediamine lyase activity and gene encoding the same
EP1568775A4 (en) CANCER ASSOCIATED GEN
EP0897984A3 (en) D-Sorbitol dehydrogenase gene

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2423858

Country of ref document: CA

Ref document number: 2002530741

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2001972537

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2001292273

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 10381710

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2001972537

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2001972537

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2001292273

Country of ref document: AU

Date of ref document: 20010927

Kind code of ref document: B